BioCentury | Nov 3, 2014
Company News

International Medica, Humanwell Healthcare Group, Shanghai BravoBio deal

...BravoBio. BravoVax did not disclose financial terms, and Humanwell could not be reached for details. International Medica...
...voluntarily withdrew it from the market in 1999 due to concerns of incidences of intussusception. International Medica Foundation...
BioCentury | Jul 22, 2013
Clinical News

RotaShield: Phase II data

...Researchers at the not-for-profit International Medica Foundation reported data from a double-blind, African Phase II trial in 998...
...of intussusception caused by RotaShield is less than previously reported (see BioCentury, Oct. 5, 2009). International Medica Foundation...
BioCentury | Jan 25, 2010
Clinical News

RotaShield: Completed Phase II enrollment

...II trial evaluating oral RotaShield given once soon after birth and again 60 days later. International Medica Foundation...
BioCentury | Oct 5, 2009
Clinical News

RotaShield: Phase II started

...that the projected incidence of intussusception caused by RotaShield is less than previously reported. The International Medica Foundation...
...the Foundation (see BioCentury, May 10, 2004). Wyeth no longer has rights to the vaccine. International Medica Foundation...
Items per page:
1 - 4 of 4
BioCentury | Nov 3, 2014
Company News

International Medica, Humanwell Healthcare Group, Shanghai BravoBio deal

...BravoBio. BravoVax did not disclose financial terms, and Humanwell could not be reached for details. International Medica...
...voluntarily withdrew it from the market in 1999 due to concerns of incidences of intussusception. International Medica Foundation...
BioCentury | Jul 22, 2013
Clinical News

RotaShield: Phase II data

...Researchers at the not-for-profit International Medica Foundation reported data from a double-blind, African Phase II trial in 998...
...of intussusception caused by RotaShield is less than previously reported (see BioCentury, Oct. 5, 2009). International Medica Foundation...
BioCentury | Jan 25, 2010
Clinical News

RotaShield: Completed Phase II enrollment

...II trial evaluating oral RotaShield given once soon after birth and again 60 days later. International Medica Foundation...
BioCentury | Oct 5, 2009
Clinical News

RotaShield: Phase II started

...that the projected incidence of intussusception caused by RotaShield is less than previously reported. The International Medica Foundation...
...the Foundation (see BioCentury, May 10, 2004). Wyeth no longer has rights to the vaccine. International Medica Foundation...
Items per page:
1 - 4 of 4